Key result
MAO-A inhibition suppresses serotonin-driven but not norepinephrine-driven cell damage in rat ventricular myocytes.
Why the study?
To evaluate the role of monoamine oxidase A (MAO-A) in serotonin- and norepinephrine-dependent cell damage, given that MAO-dependent effects are nonspecific because MAOs metabolize multiple substrates.
Does MAO-A inhibition prevent serotonin- or norepinephrine-dependent damage in rat ventricular myocytes?
Does MAO-A inhibition prevent serotonin- or norepinephrine-dependent damage in rat ventricular myocytes?
MAO-A mediates serotonin-induced, but not norepinephrine-induced, damage and oxidative stress in rat ventricular myocytes, suggesting a specific role in maladaptive hypertrophy.
Findings in rat myocytes should not alter practice; hypothesis-generating for MAO-A in hypertrophy.
Serotonin effects on cardiac hypertrophy, senescence, and failure are dependent either on activation of specific receptors or serotonin uptake and serotonin degradation by monoamine oxidases (MAOs). Receptor-dependent effects are specific for serotonin, but MAO-dependent effects are nonspecific as MAOs also metabolize other substrates such as catecholamines. Our study evaluates the role of MAO-A in serotonin- and norepinephrine-dependent cell damage. Experiments were performed in vivo to study the regulation of MAOA and MAOB expression and in vitro on isolated cultured adult rat ventricular cardiomyocytes (cultured for 24 h) to study the function of MAO-A. MAOA but not MAOB expression increased in maladaptive hypertrophic stages. Serotonin and norepinephrine induced morphologic cell damage (loss of rod-shaped cell structure). However, MAO-A inhibition suppressed serotonin-dependent but not norepinephrine-dependent damages. Serotonin but not norepinephrine caused a reduction in cell shortening in nondamaged cells. Serotonin induced mitochondria-dependent oxidative stress. In vivo, MAOA was induced during aging and hypertension but the expression of the corresponding serotonin uptake receptor (SLC6A4) was reduced and enzymes that reduce either oxidative stress (CAT) or accumulation of 5-hydroxyindolacetaldehyde (ALDH2) were induced. In summary, the data show that MAO-A potentially affects cardiomyocytes’ function but that serotonin is not necessarily the native substrate.
No takes yet. Share an insight, caveat, or question.
Knittel et al. (2023) studied Cardiac hypertrophy and cell damage. MAO-A inhibition was evaluated on Morphologic cell damage and cell shortening. MAO-A inhibition suppressed serotonin-dependent but not norepinephrine-dependent morphologic cell damage in rat ventricular myocytes, though serotonin may not be the native substrate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: